Health ❯ Healthcare ❯ Vaccines

mRNA Vaccines

COVID-19 Vaccines Moderna Lipid Nanoparticles RSV Vaccines Covid-19 Vaccines Funding Cuts Flu Vaccines Influenza Vaccines Moderna Spikevax Development and Research

Moderna’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

The findings set up an FDA decision due by August 5.

Stories older than 24h

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

Denis Logunov Named Director of Russia’s Gamaleya Research Center

Mass French Study Finds No Increase in Mortality After mRNA COVID Vaccination

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

Early H3N2 Surge Triggers EU Vaccine Push as mRNA Flu Shots Outperform in Phase 3

MIT Lipid Nanoparticle Boosts mRNA Vaccine Potency at 1/100th Dose in Mice

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

mRNA Covid Vaccination Linked to Longer Survival When Given Near Cancer Immunotherapy, Nature Study Finds

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

Phenol-Modified Lipids Improve mRNA Therapeutics by Cutting Inflammation

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

Cornell Team Unveils Zwitterionic Polymer to Enhance mRNA Vaccine Delivery

Moderna’s Combined COVID-19 and Flu Vaccine Shows Promising Phase III Results

NIH Directs Scientists to Remove mRNA Vaccine References, Raising Fears of Research Cuts